Presentation Periprocedural Bleeding and Thromboembolic Events with Dabigatran Compared to Warfarin Presenter: Jeff S. Healey June 21, 2012 REGISTER for free or LOG IN to view this content CAD Pharma ACS/AMI Coronary Factoid Up Next Presentation GI2 2012 10 Reasons Why the Metallic Drug-eluting Stent Should be Replaced by Bioresorbable Scaffold Presenter: Patrick W. Serruys April 12, 2012 More slides + Presentation RESET: Comparison of Everolimus-Eluting and Sirolimus-Eluting Coronary Stents Presenter: Takeshi Kimura July 27, 2012 Presentation TCTAP 2012 Plaque Progression and Instability: Critical Insights from Pathology Presenter: Renu Virmani April 25, 2012 We Recommend
Presentation GI2 2012 10 Reasons Why the Metallic Drug-eluting Stent Should be Replaced by Bioresorbable Scaffold Presenter: Patrick W. Serruys April 12, 2012
Presentation RESET: Comparison of Everolimus-Eluting and Sirolimus-Eluting Coronary Stents Presenter: Takeshi Kimura July 27, 2012
Presentation TCTAP 2012 Plaque Progression and Instability: Critical Insights from Pathology Presenter: Renu Virmani April 25, 2012